Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 12, 2009, Pages 1925-1931

  Burton, James O ^a   Jefferies, Helen J ^a   Selby, Nicholas M ^a   McIntyre, Christopher W ^a,b  

^a DERBY CITY GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PERFORMANCE; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE WALL MOTION; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPOTENSION; INCIDENCE; MALE; MYOCARDIAL HIBERNATION; OBSERVATIONAL STUDY; RISK ASSESSMENT; STUNNED HEART MUSCLE; SYSTOLE; SYSTOLIC DYSFUNCTION;

AGED; BLOOD PRESSURE; COMORBIDITY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, SYSTOLIC; HUMANS; HYPERTENSION, RENAL; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL STUNNING; RENAL DIALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 73649083292     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04470709     Document Type: Article

References (31)

1. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9: S16-S23, 1998
2. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD: Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63: 793-808, 2003
3. U.S. Renal Data System. Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the US. Bethesda, MD, National Institutes of Health, Diabetes and Digestive and Kidney Diseases, 2007
4. Selby NM, Lambie SH, Camici PG, Baker CS, McIntyre CW: Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis. Am J Kidney Dis 47: 830-841, 2006
5. Selby NM, Burton JO, Chesterton LJ, McIntyre CW: Dialysis induced regional left ventricular dysfunction is ameliorated by cooling the dialysate. Clin J Am Soc Nephrol 1: 1216-1225, 2006
6. Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysis-induced cardiac injury: Determinants and associated outcomes. Clin J Am Soc Nephrol 4: 914-920, 2009
7. McIntyre CW, Burton JO, Selby NM, Leccisotti L, Korsheed S, Baker CS, Camici PG: Hemodialysis induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol 3: 19-26, 2008
8. Silberberg JS, Barre PE, Prichard SS, Sniderman AD: Impact of left ventricular hypertrophy on survival in endstage renal disease. Kidney Int 36: 286-290, 1989
9. Sigrist MK, McIntyre CW: Vascular calcification is associated with impaired microcirculatory function in chronic hemodialysis patients. Nephron Clin Pract 108: c121-c126, 2008
10. Ragosta M, Samady H, Isaacs RB, Gimple LW, Sarembock IJ, Powers ER: Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries. Am Heart J 147: 1017-1023, 2004
11. Bos WJ, Bruin S, van Olden RW, Keur I, Wesseling KH, Westerhof N, Krediet RT, Arisz LA: Cardiac and hemodynamic effects of hemodialysis and ultrafiltration. Am J Kidney Dis 35: 819-826, 2000
12. Homans DC, Laxson DD, Sublett E, Lindstrom P, Bache RJ: Cumulative deterioration of myocardial function after repeated episodes of exercise-induced ischemia. Am J Physiol 256: H1462-H1471, 1989
13. Vanoverschelde JL, Wijns W, Depre C, Essamri B, Heyndrickx GR, Borgers M, Bol A, Melin JA: Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation 87: 1513-1523, 1993
14. Narula J, Dawson MS, Singh BK, Amanullah A, Acio ER, Chaudhry FA, Arani RB, Iskandrian AE: Noninvasive characterization of stunned, hibernating, remodeled and nonviable myocardium in ischemic cardiomyopathy. J Am Coll Cardiol 36: 1913-1919, 2000
15. Braunwald E, Rutherford JD: Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium". J Am Coll Cardiol 8: 1467-1470, 1986
16. Schulz R, Rose J, Martin C, Brodde OE, Heusch G: Development of short-term myocardial hibernation. Its limitation by the severity of ischemia and inotropic stimulation. Circulation 88: 684-695, 1993
17. Fallavollita JA, Canty JM Jr: Differential 18F-2-deoxyglucose uptake in viable dysfunctional myocardium with normal resting perfusion: Evidence for chronic stunning in pigs. Circulation 99: 2798-2805, 1999
18. Bosch JG, Savalle LH, van Burken G, Reiber JH: Evaluation of a semiautomatic contour detection approach in sequences of short-axis two-dimensional echocardiographic images. J Am Soc Echocardiogr 8: 810-821, 1995
19. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE: Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol 11: 912-916, 2000
20. Birnbaum Y, Kloner RA: Therapy for myocardial stunning. Basic Res Cardiol 190: 291-293, 1995
21. Sigrist M, Bungay P, Taal MW, McIntyre CW: Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant 21: 707-714, 2006
22. Blacher J, Safar ME, Guerin AP, Pannier B, Marchais SJ, London GM: Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int 63: 1852-1860, 2003
23. Freedman BI: Genetic factors in common complex renal and cardiovascular diseases. Adv Chronic Kidney Dis 13: 105-109, 2006
24. Stewart GA, Mark PB, Johnston N, Foster JE, Cowan M, Rodger RS, Dargie HJ, Jardine AG: Determinants of hypertension and left ventricular function in end stage renal failure: A pilot study using cardiovascular magnetic resonance imaging. Clin Physiol Funct Imaging 24: 387-393, 2004
25. Mall G, Huther W, Schneider J, Lundin P, Ritz E: Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant 5: 39-44, 1990
26. Wali RK, Wang GS, Gottlieb SS, Bellumkonda L, Hansalia R, Ramos E, Drachenberg C, Papadimitriou J, Brisco MA, Blahut S, Fink JC, Fisher ML, Bartlett ST, Weir MR: Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with endstage renal disease. J Am Coll Cardiol 45: 1051-1060, 2005
27. Vanholder R, Glorieux G, Lameire N: Uremic toxins and cardiovascular disease. Nephrol Dial Transplant 18: 463-466, 2003
28. Shivalkar B, Flameng W, Szilard M, Pislaru S, Borgers M, Vanhaecke J: Repeated stunning precedes myocardial hibernation in progressive multiple coronary artery obstruction. J Am Coll Cardiol 34: 2126-2136, 1999
29. Hung SY, Hung YM, Fang HC, Yeh JH, Hung GC, Wu CJ, Chou KJ, Chung HM: Cardiac troponin I and creatine kinase isoenzyme MB in patients with intradialytic hypotension. Blood Purif 22: 338-343, 2004
30. Chan C, Floras JS, Miller JA, Pierratos A: Improvement in ejection fraction by nocturnal hemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant 17: 1518-1521, 2002
31. De Lima JJ, Sabbaga E, Vieira ML, de Paula FJ, Ianhez LE, Krieger EM, Ramires JA: Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension 42: 263-268, 2003